What Researchers Did
Researchers compared two HBOT pressures -- 2.0 ATA versus 2.5 ATA -- for treating hemorrhagic radiation cystitis in a cohort of 93 patients.
What They Found
Both pressures produced significant improvements in hematuria and cystitis symptoms. The 2.5 ATA group showed slightly greater improvement in objective bleeding scores, but both protocols were considered clinically effective with comparable safety profiles.
What This Means for Canadian Patients
Hemorrhagic radiation cystitis is an OHIP-covered indication for HBOT in Ontario. This comparative study helps inform which pressure protocol may be preferred in clinical practice at Canadian hyperbaric centres.
Canadian Relevance
Covers an OHIP-covered indication: delayed radiation injury (radiation cystitis). Ontario patients with hemorrhagic radiation cystitis following pelvic cancer treatment may be eligible for publicly funded HBOT.
Study Limitations
Retrospective design and lack of randomization limit conclusions about which pressure is definitively superior.